Then you have studies that have completely different results - as this is a very heterogenous disease.
It's extremely hard to draw conclusions without proper controls.
The FDA understands this. Why do you think they asked twice for an RCT?
Then you have studies that have completely different results -...
-
- There are more pages in this discussion • 154 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
0.005(0.51%) |
Mkt cap ! $1.138B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 98.5¢ | $3.293M | 3.304M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 187269 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 19260 | 11 |
View Market Depth
| Last trade - 14.36pm 25/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |